MedPath
FDA Approval

Fluconazole

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 15, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Fluconazole(150 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

ANI Pharmaceuticals, Inc.

Golden State Medical Supply, Inc.

831049809

Products4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fluconazole

Product Details

NDC Product Code
51407-301
Application Number
ANDA078423
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 15, 2023
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92JClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
ALUMINUM OXIDEInactive
Code: LMI26O6933Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
Code: 8VZV102JFYClass: ACTIBQuantity: 150 mg in 1 1

Fluconazole

Product Details

NDC Product Code
51407-302
Application Number
ANDA078423
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 15, 2023
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92JClass: IACT
ALUMINUM OXIDEInactive
Code: LMI26O6933Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
Code: 8VZV102JFYClass: ACTIBQuantity: 200 mg in 1 1

Fluconazole

Product Details

NDC Product Code
51407-299
Application Number
ANDA078423
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 15, 2023
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92JClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
ALUMINUM OXIDEInactive
Code: LMI26O6933Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
Code: 8VZV102JFYClass: ACTIBQuantity: 50 mg in 1 1
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT

Fluconazole

Product Details

NDC Product Code
51407-300
Application Number
ANDA078423
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 15, 2023
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92JClass: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
ALUMINUM OXIDEInactive
Code: LMI26O6933Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
Code: 8VZV102JFYClass: ACTIBQuantity: 100 mg in 1 1
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
© Copyright 2025. All Rights Reserved by MedPath